Sessioni Comunicazioni Orali


Pharmacovigilance - Session I

Mercoledì 28 Ottobre 2015 / 17.15-19.00
28Estimated AUC of Mycophenolate mofetil in pediatric patients with hematopoietic cell translaptation using a reduced sampling model validated for kidney transplant
Licata S., Maximova N., Baraldo M.
60Suspected adverse reactions to contrast media in Campania Region (Italy): results from 14 years of post-marketing surveillance
Mascolo A., Rossi C., Sessa M., Fiorentino S., Grassi E., Scavone C., Reginelli A., Rotondo A., Sportiello L.
339Gastrointestinal complications and use of NSAIDs, low—dose aspirin and combination of them: results of spontaneous reporting from a Southern Italian area
Sullo MG., Ferrajolo C., Sessa M., Aiezza ML., Balzano A., Manguso F., Scarpignato C., Rafaniello C., Capuano C., Rossi F.
366Use of asthma drugs and risk of hepatotoxicity in children: a population-based, case-control study
Ferrajolo C., Capuano A., Engelkes M., Verhamme KMC., Rossi F., Sturkenboom MCJM.
520Hypoglycaemia with antidiabetic drugs: results from a prospective pharmacovigilance study in Sicily
Pizzimenti V., Ientile V., Fava G., Bonfiglio C., Alecci U., Russo A., Giandalia A., Cutroneo PM., Cucinotta D., Caputi AP., Trifirò G.
568Bleeding related to oral anticoagulant drugs as cause of emergency department admission: analysis of data from the Tuscan MEREAFaPS Network
Saporiti A., Capogrosso-Sansone A., Mantarro S., Convertino I., Montagnani S., Marino A., Rossi M., Moschini M., Vannacci A., Santini M., Spisni L., Blandizzi C., Tuccori M.
656Drug therapy and other risk factors for hypoglycemia in patients with type 2 diabetes, hospitalized in Internal Medicine wards. Findings from the FADOI- DIAMOND Study
Gussoni G., Frasson S., Borzì V., Fontanella A., Grandi M., Gulli G., Pastorelli R., Solerte B., Ceriello A., Vescovo G., Agnelli G., Campanini M.